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ABSTRACT: The use of coumarin caged molecules has been
well documented in numerous photocaging applications
including for the spatiotemporal control of Cre-estrogen
receptor (Cre-ERT2) recombinase activity. In this article, we
report that 4-hydroxytamoxifen (4OHT) caged with coumarin
via a conventional ether linkage led to an unexpected photo-
Claisen rearrangement which significantly competed with the
release of free 4OHT. The basis for this unwanted reaction
appears to be related to the coumarin structure and its radical-
based mechanism of uncaging, as it did not occur in ortho-
nitrobenzyl (ONB) caged 4OHT that was otherwise linked in
the same manner. In an effort to perform design optimization, we introduced a self-immolative linker longer than the ether
linkage and identified an optimal linker which allowed rapid 4OHT release by both single-photon and two-photon absorption
mechanisms. The ability of this construct to actively control Cre-ERT2 mediated gene modifications was investigated in mouse
embryonic fibroblasts (MEFs) in which the expression of a green fluorescent protein (GFP) reporter dependent gene
recombination was controlled by 4OHT release and measured by confocal fluorescence microscopy and flow cytometry. In
summary, we report the implications of this photo-Claisen rearrangement in coumarin caged compounds and demonstrate a
rational linker strategy for addressing this unwanted side reaction.
The application of photocaging technology1−3 has yieldednumerous novel photoprobes that have enabled the active
control of molecular activities and cellular processes by light.
The fundamental concept behind these strategies is the
temporary inactivation of a biologically active molecule through
the covalent attachment of a photocleavable cage molecule until
the caged molecule is reactivated by light exposure.2 Several
types of cage molecules, each distinct in their structural and
photochemical properties,4−6 have been reported, including
ortho-nitrobenzene (ONB),1,7,8 coumarin,9,10 nitrobenzofur-
an,11 and quinoline12 chromophores. The contributions of
their applications have been well documented in numerous
fields ranging from ion channels1,13 and enzymes14,15 to gene
expression,16 photopharmacology,17,18 and controlled drug
transport or delivery.19−21
Recently, a number of laboratories,22−24 including ours,25,26
have reported on caged forms of ligands for the estrogen
receptor (ER), such as tamoxifen (TAM),26 4-hydroxytamox-
ifen (4OHT),25,27 and their homologues,22−24 and have
validated their ability to control light-inducible reporter gene
modifications in optogenetic models.23,28 In our studies,25,26 we
used transgenic mouse embryonic fibroblasts (MEFs) with a
reporter cassette (mTmG29) which contains a gene for red
fluorescent protein (RFP) TdTomato flanked by loxP sites
(Figure 1). These MEFs also constitutively express Cre
recombinase fused to a modified ER that has a reduced affinity
for native estrogen (UbcCre-ERT230). In the absence of ER
ligand, Cre-ERT2 recombinase remains bound to cytoplasmic
Hsp70, and the MEFs constitutively express RFP. However,
upon binding uncaged ligand, Cre-ERT2 dissociates from
Hsp70 and is translocated to the nucleus where it can then
excise the Loxp-flanked gene for TdTomato from the mTmG29
reporter construct, resulting in the expression of a membrane-
bound green fluorescence protein (GFP). We reported that 1
ONB-L1-4OHT, which is highly water-soluble (≥20 mg mL−1)
and cell permeable, has the ability to induce reporter expression
with a spatial resolution sufficient for selectively marking cells.25
The uncaging efficiency of tamoxifen caged compounds
reported in existing Cre-ER models is based on a single-photon
mechanism of activation which typically occurs by absorption of
light in the UV range. However, the efficiency of two-photon
mechanisms of activation which use longer wavelength, near-
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infrared (NIR) light remains mostly unevaluated.24 Two-
photon uncaging of photocaged compounds occurs only on
the focal plane with small cross sections of absorption,6 but it
offers significant unique advantages over the single-photon UV
activation including the deeper penetration capabilities of NIR
light in tissue, as well as reduced light scattering and greater
spatial resolution.6,9 Subsequently, our current efforts focused
on the design and validation of new 4OHT caged compounds
for their uncaging efficiency by both single- and two-photon
mechanisms in vitro.
Here, we discuss the light-controlled recombinase activity
observed in the two series of 4OHT-caged compounds, the first
based on the ONB cage including 1 ONB-L1-4OHT, and the
second based on the coumarin cage which was selected for its
susceptibility to one-photon uncaging by UV−visible light
(405−420 nm)7,31,32 as well as for its enhanced cross sections
for two-photon uncaging (δuncaging/GM = 0.21−1.99) compared
to ONB (δuncaging/GM = 0.01−0.23).
6 The importance of linker
selection in the design of 4OHT caged compounds was then
examined. Despite its important role in conjugation chemistry,
the “linkage” or “linker” (linkage + spacer) is generally less
prioritized in the design of caged compounds than the cage
itself because it has hitherto been thought of as playing no
direct role in triggering the uncaging reaction and having no
contribution to the wavelength selectivity of the cage. Here, we
provide evidence that the use of a standard linker can lead to
poor uncaging efficiency, as illustrated by the dramatically
reduced uncaging efficiency of a coumarin cage attached
directly to the phenolic substrate, 4OHT, through an ether
linkage. Specifically, use of this linkage led to the unanticipated
occurrence of a photo-Claisen rearrangement33 as the major
reaction path and thus significantly reduced the efficiency of
free drug release. We demonstrate that the occurrence of such
undesired reaction is effectively blocked by application of
alternative linker chemistry.
■ RESULTS AND DISCUSSION
Synthesis of Coumarin Caged 4OHT via Ether Link-
age. Using a similar linker strategy applied for ONB-based
compound 1,25 we designed two coumarin caged compounds
of 4OHT, 2 BHC-L1-4OHT, and 3 COM-L1-4OHT (Figure
1), each by tethering 4OHT (Z and E isomers) at its phenolic
moiety to a BHC (6-bromo-7-hydroxycoumarin-4-methyl)9 or
COM (6-diethylaminocoumarin-4-methyl)7 cage molecule
through an ether linkage. The synthesis of 2 and 3 was
performed by direct O-alkylation of 4OHT with the
corresponding coumarinyl-4-methylmethanesulfonate. Each of
these caged compounds was obtained with a purity of ≥95%
(UPLC) without detectable free 4OHT (Figure S6, Supporting
Information). Their structural identity was fully characterized
by a combination of standard analytical methods including
NMR (1H, 13C) spectroscopy (Figures S1−S5), mass
spectrometry, and UV−vis spectrophotometry (Supporting
Information). The exact molecualr masses of 2 and 3 are in
good agreement with the experimetal values measured by high
resolution mass spectrometry (HRMS): calcd for 2
C36H34BrNO5 [M + H]
+, 640.1693; found, 640.1711; calcd
for 3 C40H44N2O4 [M + H]
+, 617.3374; found, 617.3373.
Unusual Release Kinetics of 2 and 3.We investigated the
efficiency of light-controlled release of 4OHT from 2 by
exposure to long wavelength UVA light (max intensity at 365
nm; Figure 2). After photolysis, the exposed solutions were
Figure 1. Photocontrol of Cre-ER mediated GFP expression. (A) Schematic for light-triggered activation of photocaged tamoxifen (TAM) or 4-
hydroxytamoxifen (4OHT), and the control of reporter gene expression mediated by the Cre recombinase-estrogen receptor (ER) fusion protein.
(B) Structures of 4OHT and its caged compounds including a previously reported 1 ONB-L1-4OHT,
25 and two new compounds 2 BHC-L1-4OHT
and 3 COM-L1-4OHT, each caged with BHC or COM through an ether linkage (L1), respectively. Abbreviations: ONB = ortho-nitrobenzyl; BHC =
6-bromo-7-hydroxycoumarin-4-methyl; COM = 6-diethylaminocoumarin-4-methyl.
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analyzed by thin layer chromatography (TLC; Figure S7),
which demonstrated the rapid disappearance of 2 with the
concomitant growth of a broad spot that migrated as far as the
4OHT reference molecule. However, while subsequent
quantitative analysis performed by ultrahigh performance liquid
chromatography (UPLC) also indicated the release of 4OHT, it
revealed that it was only as a minor fraction of the total
products (Φ4OHT = 0.09). The majority of the product
consisted of a pair of closely running, unknown products (tr
= 10 min) with the ∼1:2 AUC (area under curve) ratio of the
total of these two peaks relative to the 4OHT peak (Figure
2C). The unknown products were isolated by flash column
chromatography, and their structural identity was assigned as 4
(Z/E isomers) based on the combination of data from 1H
NMR spectroscopy and LC-MS mass spectrometry. Thus,
analysis of the LC−MS data indicated no change in the
molecular mass ([M + H]+ = 640.1680) compared to the
parent caged molecule 2 (Figure S8). The 1H NMR spectral
analysis shows alterations broadly in 4OHT and BHC signals
(Figure S9), in particular, in those from C-3 and C-4 protons
which are assigned in reference to C3- or C4-substituted
coumarin compounds (Table S1).34,35 On the basis of these
data, we believe that 4 was formed via the photo-Claisen
rearrangement33 of 2 as proposed in Figure 2 with a quantum
efficiency (ΦPhoto‑Claisen = 0.22) greater than that of 4OHT
release (Φ4OHT = 0.09). The occurrence of these unexpected
products from 2 is, in retrospect, explained by its [3,3] bond
framework, which is composed of an allyl (BHC)-to-aryl
(4OHT) ether, a unique structural feature required for the
occurrence of photo-Claisen rearrangement.33,36
However, it is noteworthy that 1 ONB-L1-4OHT, which
similarly meets a structural requirement by having an allyl
(ONB)-to-aryl ether framework, did not show such byproduct
formation but, instead, released 4OHT predominantly as a
single product (Φ4OHT = 0.13) in our earlier study.
25 We
further investigated whether such differences in the product
distribution between 1 and 2 are specifically inherent to the
coumarin cage by performing the release study with 3 COM-
L1-4OHT, a close analogue of 2. Its product distribution was
consistent with that of 2, demonstrating 4OHT release as a
minor fraction of the products (Φ4OHT = 0.03) along with a
larger fraction of isomeric products (ΦPhoto‑Claisen = 0.05) which
are identical to 3 in their molecular masses as characterized by
LC-MS mass spectrometry ([M + H]+ = 617.3369; Figure
S10). These results suggest that photo-Claisen products might
occur selectively for coumarin caged molecules, while the
differences observed in quantum efficiency between BHC and
COM might be determined by the nature of the aromatic ring
substituents on each coumarin cage.
Use of coumarin caged molecules has gained strong
popularity due to their high quantum efficiency of uncaging
and broad applicability to various functional substrates.6
However, the photochemical properties of the coumarin cage
which are responsible for leading to a dead-end side product
instead of the desired uncaging reaction have rarely been noted
except for the recent identification of the photoisomerization of
BHC caged cysteine-containing peptides (C4−CH2S to C3−S)
by Distefano et al.37 and Hagen et al.,31 and the photo-
rearrangement of 4-coumarinylmethyl phenyl ethers by Hagen
and co-workers.34 Thus, our study offers strong evidence for
the broader occurrence of photorearrangement specifically in
Figure 2. Mechanism of photo-Claisen rearrangement. (A) Two competing reaction paths of 2 BHC-L1-4OHT (Z and E isomers) that occur in
response to light (365 nm); path A leading to free 4OHT and path B toward the formation of a major byproduct 4 (Z/E isomers) via photo-Claisen
rearrangement. (B) Overlaid UV−vis spectra. Inset (B): a plot of absorbance at 328 nm against UV exposure time. (C) UPLC traces acquired for
references and photolyzed 2 (78 μM in 20% (v/v) aqueous methanol).
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the class of coumarin caged compounds designed with a direct
ether linkage to a target molecule. It also shows that this
rearrangement reaction significantly reduces the uncaging
efficiency and suggests the need for improving the design
features in coumarin caged compounds.
Coumarin Caged 4OHT via Extended Linker. We
hypothesize that the selective occurrence of photo-Claisen
rearrangement in the ether-linked coumarin caged compounds
is attributable to the radical mechanism of C−O bond cleavage
in combination with physical proximity between the two radical
species formed that allows recombination before they escape
from their solvent cage (Figure 2).33 To circumvent such
proximity-promoted photo-Claisen rearrangement, we focused
our design approach on extension of the linkage through either
a self-immolative38,39 carbonate (L2) or carbamate linker (L3)
that provides an effective physical barrier to separate two radical
species to be formed far enough for their escape and release.
Use of these extended linkers was previously reported for
photocaged compounds including BHC-caged ceramides
(carbonate linkage),40 ONB-caged rapamycin (carbonate),15
and ONB-caged 4OHT (carbamate).25 Application of these
two linkers led to the synthesis of two classes of caged
compounds 5−8 as shown in Figure 3: (i) the carbonate-linked
5 BHC-L2-4OHT; (ii) the carbamate-linked 6 ONB-L3-
4OHT,25 7 BHC-L3-4OHT, and 8 COM-L3-4OHT. Com-
pound homogeneity was ≥95% for each of these caged
compounds as determined by UPLC analysis (Figure S6), and
their structural identity was fully supported by data collected by
standard analytical methods as described above (Supporting
Information).
Release Kinetics of Extended Linkers.We next evaluated
the release kinetics of 5 BHC-L2-4OHT (125 μM in 20% (v/v)
aqueous methanol) upon exposure to UVA light (Figure S11).
UPLC analysis of the photolyzed solution indicated rapid
release of 4OHT (73% after 2 min). However, its 4OHT
release was also observed in the dark (9% at 2 h), pointing to
the hydrolytic instability of the carbonate linkage in 5 in the
aqueous solution.
We then investigated the release kinetics of the carbamate-
linked caged compounds 7 and 8. Exposure to UVA light
triggered the release of free 4OHT through formation of its
carbamate derivative 9 (Figure 4, Figure S12). UPLC analysis
indicates that drug release occurred in an exposure time-
dependent manner and resulted in ∼70% release of 4OHT and
its direct precursor 9 after exposure for 5 min (7) and 10 min
(8). 4OHT release was also confirmed by LC-MS mass
Figure 3. Design of extended spacers. (A) Release mechanism of extended linkers for coumarin-caged phenolic compounds in which photo-Claisen
[1,3] rearrangement is forbidden due to a lack of close proximity, and self-immolation occurs instead. (B) Two linker classes used in coumarin or
ONB-caged 4OHT compounds 5−8. 4OHT is tethered to each cage molecule through a carbonate (L2) or carbamate (L3) linker.
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spectrometric analysis, which showed the appearance of a single
peak corresponding to free 4OHT ([M + H]+ = 388.2269;
Figure S13). Regression analysis of the decay curve of 7 or 8 (%
AUC, Figure 4C) over the exposure time suggests that 7 is
consumed with a rate constant (first-order decay, k) of 0.343
min−1, which is faster than that of 8 (k = 0.192 min−1) at a
comparable concentration. The greater decay rate of 7 is
positively correlated with its higher rate of 4OHT release
(Figure 4D), suggesting that its initial cleavage to 9 which is
triggered by light serves as the rate-determining step for the
release of a drug. As a consequence, the quantum efficiency of
uncaging (Φ[4OHT+9]) calculated for 7 (0.21) is higher than
those of 6 (0.05) and 8 (0.07) as summarized in Table 1. This
greater release efficiency suggests an advantage of using 7 over
8 as the more promising probe for two-photon activation and
reporter gene expression in cells as discussed below.
In summary, the two extended linker classes investigated here
are distinguished not only by the aqueous stability of their
linkages but also by their modes of achieving drug release. First,
the carbonate linker used in 5 shows excellent photochemical
ability to release free 4OHT with a decay rate greater than
either of the carbamate-linked compounds, 7 or 8. However, it
lacks sufficient chemical stability in aqueous solution, which is
needed for precise active control. Such instability is anticipated
to be worse in cell media and in in vivo environments that
contain substantially higher concentrations (mM) of various
nucleophilic species such as amino acids, amines, and protein
molecules. This insufficient stability of the carbonate linkage as
observed in 5 was not noted previously in other caged
compounds linked through a carbonate moiety to the ONB15
or BHC40 cage, indicating perhaps the involvement of other
additional factors such as the steric effect of the substrate
molecules themselves. In contrast, the carbamate-linked
compounds 7 or 8 show good stability in aqueous solution
with no decomposition detected for either compound, at least
during the entire incubation period of up to 24 h as determined
by UPLC analysis.
The mechanism of 4OHT release by 5 involves photo-
cleavage of the CH2−OC(O) bond followed by a loss of
CO2 to yield free 4OHT (Figure 3). Similarly, both 7 and 8 rely
on the same type of photocleavage reaction but instead yield
release of 9, a 4OHT precursor. However, this derivative
Figure 4. Release kinetics of coumarin-caged 4OHT. (A) A mechanism for the photoactivation of 7 BHC-L3-4OHT and 8 COM-L3-4OHT that
involves cleavage to 9 spacer-4OHT, and subsequent self-immolative cyclization of 9, resulting in release of 4OHT. (B, C) UV−vis spectra and
UPLC traces obtained after the photolysis of 7 (110 μM, 20% (v/v) aqueous methanol) as a function of exposure time. (D) A plot of the
photochemical release kinetics of products (4OHT + 9; %AUC from UPLC traces), each from 7 or 8, respectively.
Table 1. Summary of the Photochemical Properties of Caged
4-Hydroxytamoxifen (4OHT) Compounds
Φa
cage-linker
(Ln)-4OHT linkage
λmax, nm (ε,
M−1 cm−1) 4OHT
photo-
Claisen 4
4OHT
+ 9
1 ONB-L1-
4OHTref25
ether 340 (390) 0.13 nd
2 BHC-L1-
4OHT
ether 328 (8,787) 0.09 0.22
3 COM-L1-
4OHT
ether 394 (11,357) 0.03 0.05
5 BHC-L2-
4OHT
carbonate 340 (6,154) 0.11b nd
6 ONB-L3-
4OHTref25
carbamate 340 (317) nd 0.05
7 BHC-L3-
4OHT
carbamate 330 (9,990) nd 0.21
8 COM-L3-
4OHT
carbamate 394 (13,500) nd 0.07
aSingle-photon quantum efficiency Φ = [dc/dt]initial/[qn,p(1−10−A)]
where qn.p = photon flux (qp/NA = 11.65 × 10
−8 mol s−1) measured by
ferrioxalate actinometry (Φ = 1.26);41,42 A = absorbance at 365 nm;
dc/dt = initial rate of 4OHT release or Claisen product (mol s−1).42
bContribution from nonphotochemical (preexisting) hydrolysis
excluded. nd = not detectable
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subsequently undergoes intramolecular self-immolation38,39
through its spacer methyl(2-(methylamino)ethyl)carbamate25
to release free 4OHT. Our observation that 7 shows both a
greater decay rate and a higher quantum efficiency of 4OHT
release than 8 (Table 1, Figure 4) clearly indicates that BHC in
7 is more effective in triggering the first photocleavage reaction
than COM in 8.
Cre-ERT2 Mediated GFP Expression in Vitro. After
validation of 4OHT release kinetics in solution, we selected two
coumarin caged compounds 2 BHC-L1-4OHT and 7 BHC-L3-
4OHT to compare their ability to control GFP expression in
UbcCreERT2 mTmG MEF reporter cells (Figure 5). This cell
line constitutively expresses Cre-ERT2 from the ubiquitin
promoter and contains an mTmG reporter cassette which
contains a loxp flanked gene for membrane bound red
fluorescent protein (RFP), tdTomato.25,26 TdTomato is
constitutively expressed. However, upon Cre-ERT2 binding
of free 4OHT, the loxP-flanked RFP gene is deleted by the
translocated Cre recombinase, and a membrane bound GFP
protein is expressed instead.
We first examined the photocontrol of the 4OHT constructs
in the modulation of such switches in the expression of the
reporter gene using confocal fluorescence microscopy. As
similar to a published Protocol,25 MEFs were treated with
4OHT, 2, or 7, each at a concentration of 250 nM in media and
exposed to UVA light for 3 min, as this exposure time falls
within the middle of the optimal exposure range for uncaging of
all of the compounds tested (Figure 4). The cells were
subsequently incubated at 37 °C for 24 h prior to being
processed for confocal imaging. Cells treated with media alone
and cells treated with each caged compound in the absence of
UVA exposure demonstrated a lack in detectable GFP
fluorescence (Figure 5). Furthermore, untreated cells exposed
to UVA for 3 min also showed no GFP fluorescence (Figure
S14). In contrast, as a positive control, MEFs were treated with
free 4OHT, which led to a detectable increase in GFP
fluorescence even in the absence of UVA.
Cells treated with 2 or 7 with UVA exposure (+UVA; right)
resulted in a substantial increase in GFP fluorescence intensity
compared to the treated cells without UV exposure (left),
validating UVA mediated photo-uncaging. However, GFP
fluorescence induced by 2 appeared to be weaker than that
induced by 7. While these differences between the activities of
the two compounds as observed by confocal microscopy are
only qualitative, these results are consistent with the release
kinetics observed in solution where the release of free 4OHT
upon UVA exposure was more efficient for 7 than for 2, the
ether-linked compound that suffered from the photo-Claisen
rearrangement as the major pathway for photocleavage. In
contrast, a similar experiment with 5 BHC-L2-4OHT (±UVA)
indicates its potent activity in inducing GFP expression, but
with a lack of UV-mediated control (Figure S14), which is
consistent with its hydrolytic instability in aqueous solutions
(Figure S11). In summary, these confocal results are supportive
of the ability of 4OHT caged compounds to control the
induction of GFP expression through Cre-ERT2 recombinase
activity in response to light. Our ongoing and future efforts are
focused on developing and validating an efficient method of
applying the probe 7 for spatiotemporal reporter activation in
vivo as illustrated in Figure S15.
Two-Photon Uncaging in Vitro. After validation of release
kinetics by single-photon exposure, we determined the
Figure 5. Confocal fluorescence microscopy analysis of the photocontrol of Cre-ERT2 mediated GFP expression in UbcCreERT2 mTmG MEF
cells. As controls, MEFs were treated with (A) media alone or (B) 4OHT without UVA exposure. MEFs were treated with 2 BHC-L1-4OHT (C)
without or (D) with UVA exposure. MEFs were treated with 7 BHC-L3-4OHT (E) without or (F) with UVA exposure. [4OHT or caged
compound] = 250 nM. UVA exposure time = 3 min tdTomato fluorescence (red) and GFP fluorescence (green) are shown. Nuclei were labeled
with DAPI (blue).
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efficiency by which these compounds were uncaged by two-
photon excitation (Figure 6). ONB groups have been reported
to have narrow two-photon cross sections of absorption in the
750 nm range while coumarin (COM, BHC) cages have
broader two-photon cross sections in the 800 nm range.6 This
means that coumarin cages uncage more efficiently at
wavelengths more useful for use in tissue. As such we tested
the uncaging efficiency of 1 ONB-L1-4OHT and 6 ONB-L3-
4OHT by two-photon illumination at 730 and 750 nm, and 3
COM-L1-4OHT by two-photon illumination at each of three
different wavelengths (780, 800, 820 nm) at various laser
powers. To get significant uncaging (≥2% GFP+) of 1, 240
mW illumination was required at 750 nm for 10 min while %
GFP+ was positively correlated with the irradiation time with a
maximum value of ∼8% (Figure 6A,B). However, even at this
high power, 3 and 6 showed no appreciable uncaging (Figure
6C,D). The efficiency of uncaging of 1 could be improved by
increasing the time of the exposure (Figure 6B); however at
240 mW, two-photon illumination using a pulsed laser at 750
nm would damage tissues which would be exacerbated by these
long exposures. Compound 1 was more efficiently activated
than 6 by two-photon illumination, consistent with the
increased decay rate seen with single photon illumination.
Since 3 COM-L1-4OHT undergoes such a significant side
reaction, it is likely this lack of uncaging is due to this inefficient
uncaging. As such, we compared the efficiency of uncaging of
BHC caged compounds 2 BHC-L1-4OHT and 7 BHC-L3-
4OHT at wavelengths between 800 and 840 nm (Figure 6E,F).
These uncaging experiments were performed at the concen-
tration which is either identical to that used in Cre-ERT2
Figure 6. Two-photon activation of caged 4OHT compounds 1, 2, 3, 6, and 7. (A, C, D) Hanging drops of 1, 3, and 6 were exposed to IR light for
10 min on the order of 5 × 1010 pulses (80 fs, 80 MHz) at different wavelengths at various powers. The uncaged compound solution was then
diluted and added to UbcCre-ERT2 mTmG MEFs. At 24 h, the percent of GFP+ cells was determined by flow cytometry. Values of %GFP+ cells
reported here refer to those obtained values after background correction by subtraction of the signal from cells exposed to a vehicle (DMSO) which
was set to 0. (B) The above process was repeated with 1 for various irradiation times at 750 nm at 240 mW. (E, F) Compounds 2 and 7 were
irradiated at different wavelengths for 10 min at 120 mW, and these were similarly used to convert reporter MEFs. The percent GFP+ cells was
measured by flow cytometry. [1] = 100 nM, [2] = 2.5 μM, [3] = 50 nM, [6] = 200 nM, [7] = 250 nM. *P < 0.05.
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mediated GFP expression (250 nM for 7; Figure 5) or higher
(2.5 μM for 2) due to its relatively low efficiency of 4OHT
release. Hanging drops of 2 and 7 were illuminated for 10 min
at 120 mW laser power. Both 2 and 7 showed uncaging activity
at 800 nm, and similar to the observations made for single-
photon uncaging, 7 was also uncaged most efficiently by two-
photon excitation. Indeed at 120 mW power for 10 min, 7 was
6 times more active in inducing GFP expression than 1 (2.7%
GFP+ compared to 0.4% GFP+). The carbonate linked
compound 5 was not tested for two photon uncaging as it is
unstable in aqueous solutions and so was as potent at inducing
GFP expression with or without UVA illumination (Figure
S14).
Conclusion. In summary, we designed a series of new
4OHT probes caged with coumarin through the extended
spacer for light controlled GFP gene expression in
UbcCreERT2 mTmG MEFs and validated their effective
uncaging activity in vitro by both single- and two-photon
mechanisms. We believe that this study represents a significant
advancement and gives new insights into the development of
photoprobes that enable precise control of cell labeling based
on a Cre-ER reporter system. Uncaging by single-photon
irradiation occurred rapidly, in as short of an exposure time as 2
min for both BHC and COM caged compounds, with quantum
efficiency (Φ) as high as 0.21 (Φ, Table 1). BHC caged
compounds exhibited more effective uncaging than their COM
analogues. A representative compound, 7, was activated on
MEFs by UVA, demonstrating its ability to temporally induce
GFP reporter expression.
Uncaging by two-photon irradiation induced an increase in
the %GFP+ cells as high as 8% for certain caged compounds
(Figure 6), though this was less efficient than that observed by
single-photon irradiation (UVA).25 This result was anticipated
due to the generally lower efficiency of uncaging by two-
photon.5,6 The two-photon efficiency was dependent on the
structural type of the cage, with BHC (7) showing greater GFP
expression than ONB (1). Such higher efficiency by BHC is
attributable primarily to its higher two-photon cross-section of
absorption (δabsorption) rather than its quantum efficiency of
uncaging (Φ = 0.21), which is not significantly higher than that
of ONB (Φ = 0.13, Table 1). In addition, two-photon factors
including irradiation wavelength, intensity, and exposure time
made a significant contribution to the uncaging efficiency.
However, due to the inability to have direct correlation between
the two-photon and single-photon factors, systematic screening
of these parameters for each compound was needed for the
identification of the optimal uncaging conditions as done in this
study.
We believe that this study offers rare insights into the
mechanism of the photouncaging process and has broad
implications in the field of photocaging technology. Despite the
extensive use of coumarin caged compounds,3,6,37 only few
previous studies have indicated the occurrence of photo-
rearrangement in caged thiols and phenols.31,34,37 Our present
study reports on the prevalence of photo-Claisen rearrange-
ment33,36 in coumarin ether caged compounds, but no evidence
is observed for the implication of such rearrangement in ONB
uncaging, which occurs exclusively via an intramolecular
cyclization of its nitro group.6 We attribute the basis of this
photorearrangement to the radical-based mechanism of
coumarin uncaging in combination with the presence of an
ether linkage which, due to its shorter length in nature, brings
the transient radical species generated by light exposure into
close proximity, thus promoting their recombination.33 We
suggest the incorporation of an extended linker as an effective
strategy to circumvent its negative effect on uncaging efficiency.
Use of this strategy enabled us to block this rearrangement
possibly by sufficiently separating the two radical species within
their solvent cages and thus preventing their recombination.
The photo-Claisen byproduct formed was not detectable by
methods commonly used in this field such as UV−vis
spectrometry (Figure 2B) or by TLC analysis, which had
insufficient resolution of separation (Figure S7). Instead, its
detection and quantitation required the development of a
specific UPLC method that provides sufficient product
resolution. Thus, this study highlights the importance of linker
development in the design of 4OHT caged compounds, as well
as in the design of other photocaged compounds, and
underscores the importance of analytical method choice for
evaluating the formed products. It is notable that a lack of such
precise analysis can result in inaccurate interpretation of
biological activities in vitro and in vivo as some of the
byproduct-like C-4 substituted coumarin compounds are
associated with promiscuous activities such as acting as ligands
of estrogen receptors,43 antioxidants,44 and antiviral agents.45
■ MATERIALS AND METHODS
Methods for the synthesis of caged 4OHT compounds and analytical
methods (1H and 13C NMR spectroscopy, UV−vis spectrometry, mass
spectrometry, UPLC) are described in detail in the Supporting
Information and the references cited therein. Full details for release
kinetics25,26 and cell studies in vitro (single-photon25 and two-photon13
uncaging for induction of GFP expression) are also provided in the
Supporting Information.
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